Most private equity diligence is excellent at identifying what a company has achieved. Far fewer firms have reliable visibility into whether the organization can sustain it, scale it, or survive the demands of your value creation plan. SCALE closes that gap.
60–70% of PE-backed companies experience a CEO change during ownership — and more than 60% of those replacements are first-time CEOs. Source: McKinsey Global Private Markets Report, 2026
20–30% of private equity investments fail — and the root cause is rarely financial. Leadership weakness, governance gaps, and execution constraints are consistent factors in underperformance. Source: Guide for Investment, 2025
Only 35% of C-suite executives rate their board as "good" or "excellent" — and 93% advocate for replacing at least one director. Source: PwC Board Effectiveness Survey, 2025
70% of operating partners believe portfolio management teams are too slow to execute. 60% of portfolio leaders cite unrealistic sponsor expectations. The gap between the two is an organizational problem, not a financial one. Source: AlixPartners Survey of 400 PE Professionals, 2023
Acquisition Diligence
The Diligence Gap Most Firms Don't See
Financial, legal, and commercial diligence tell you what you're buying. They rarely tell you whether the organization can execute what you're planning.
Founder dependencies. Weak leadership bench. Informal decision-making. Passive boards. Succession gaps. These don't appear in quality of earnings reports, but they consistently show up in investments that underperform.
SCALE surfaces the organizational realities that traditional diligence misses, as strategic alignment, leadership capacity, governance maturity, execution discipline, and enterprise resilience are evaluated before capital is deployed.
The result is a clearer picture of what you're actually acquiring, and what intervention the investment thesis will require.
What acquisition teams gain:
Hidden organizational risk identified before close
Leadership capacity stress-tested against the value creation plan
Governance maturity and board effectiveness assessed
Founder dependency and succession risk quantified
Post-close priorities established with evidence, not assumptions
Value Creation
When Execution Becomes the Constraint
Most value creation plans fail not because the strategy was wrong, but because the organization couldn't carry it. As companies scale under PE ownership, organizational complexity frequently outpaces the systems built to manage it. These common situations arise: leadership bottlenecks form, accountability structures blur, and decision-making slows. The plan stalls while the clock runs.
SCALE identifies where growth is creating strain before it becomes visible in financial results. By evaluating the five dimensions of organizational health; strategy, execution, leadership, governance, and resilience, firms gain a precise map of where capacity constraints exist and where investment in organizational infrastructure will unlock the most value.
What operating partners gain:
Bottlenecks identified before they delay the value creation timeline
Leadership alignment assessed against the specific demands of the thesis
Accountability gaps surfaced early — not after performance misses
Organizational capacity matched to growth expectations
Clear prioritization of where to invest operating partner attention
Portfolio Oversight
Exit Preparation
Portfolio Benchmarking & Governance Intelligence
See What Financial Reporting Doesn't Show
Financial results reveal outcomes. They rarely explain the organizational conditions producing them, or signal what's coming next. SCALE provides a consistent organizational health view across every portfolio company: how leadership teams are functioning, whether governance structures are keeping pace with growth, where decision-making quality is strong or deteriorating, and which companies are drifting from the conditions that made them attractive acquisitions.
Combined with BoardPulse, SagaciousThink's board effectiveness diagnostic, firms gain visibility into how directors perceive risk, strategy, and leadership effectiveness. That creates an early-warning capability that identifies governance drift and leadership misalignment before they become performance problems.
What portfolio managers gain:
Consistent organizational health benchmarks across all portfolio companies
Early identification of drift, bottlenecks, and governance deterioration
Board-management alignment visibility
A basis for prioritizing operating partner time and intervention
Intelligence that supplements, and explains, the financial reporting
Buyers Are Looking Beyond the Financials
Sophisticated buyers today don't just evaluate historical performance. They evaluate whether the organization can sustain and scale what it has built, without the PE sponsor in the room. Leadership depth, governance maturity, succession readiness, board quality, and organizational discipline increasingly influence both buyer confidence and transaction valuation. Gaps in any of these areas introduce diligence risk, buyer leverage, and deal friction.
SCALE helps portfolio companies enter an exit process with evidence, not just a narrative, of organizational readiness. The diagnostic outputs translate directly into the language of acquirer diligence: clear governance structures, demonstrated leadership depth, documented succession plans, and measurable organizational resilience. The result is a stronger story, a more confident management team, and a process where the organizational dimension of the business is a differentiator, not a liability.
What deal teams gain at exit:
Evidence of governance maturity and board effectiveness
Leadership bench depth documented and demonstrable
Organizational resilience positioned as a value driver
Reduced buyer diligence risk in areas most likely to generate friction
A stronger, more credible management narrative
Know Where to Focus. Know Why Performance Is Changing.
Not all portfolio companies require the same operating partner attention. And not all performance changes have the same organizational root cause. Without consistent diagnostic data across the portfolio, those distinctions are difficult to make with confidence. SCALE enables firms to benchmark organizational health, governance maturity, leadership effectiveness, and execution capacity across every investment, using a consistent methodology that produces comparable data.
Over time, that benchmarking reveals patterns that go beyond individual companies: which organizational conditions predict successful value creation, which governance structures correlate with exit readiness, and where early intervention prevents late-stage performance risk.
For firms building or refining their operating playbook, SCALE becomes the intelligence layer beneath the financial data, explaining not just what is happening across the portfolio, but why.
What portfolio intelligence enables:
Portfolio-wide organizational benchmarking on a consistent methodology
Drift monitoring that identifies deterioration before it becomes financial
Identification of recurring organizational risk patterns across investments
Data that informs acquisition profiles, operating playbooks, and LP reporting
A basis for demonstrating operational value creation discipline to LPs